XOFLUZA (Baloxavir Marboxil) Tablets 10mg/20mg for the Treatment of Influenza Types A and B launched in Japan
(WorldNews Asia)

XOFLUZATM (Baloxavir Marboxil) Tablets 10mg/20mg for the Treatment of Influenza Types A and B launched in Japan Osaka, Japan, March 14, 2018 - Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") would like to announce that Shionogi launched XOFLUZATM (generic name: baloxavir marboxil) tablets 10mg/20mg for the treatment of Influenza Types A and B in Japan. As the cap-dependent endonuclease inhibitor XOFLUZATM suppresses the replication of influenza viruses by a mechanism different from existing anti-flu drugs. XOFLUZATM is an oral tablet that will be dosed only once, offering improved compliances and convenience to the...